Crohn's Disease: Inflammatory Bowel Diseases: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Proctitis: Anal and Rectal Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
AXP-111/LOWREZ.FR page 3
author: Mario
duplicates:http://www.axcan.com/fr-fr/pdf/Q3-F.pdf http://www.axcan.com/fr-ca/pdf/Q3-F.pdf
Axcan_Couverts page 27
author: poste 4
duplicates:http://www.axcan.com/fr-fr/pdf/rap01_fr.pdf http://www.axcan.com/fr-ca/pdf/rap01_fr.pdf
Axcan_Couverts page 26
author: poste 4
duplicates:http://www.axcan.com/fr-fr/pdf/rap01_fr.pdf http://www.axcan.com/fr-ca/pdf/rap01_fr.pdf
http://www.axcan.com/pdf/rap00_fr.pdf page 24
duplicates:http://www.axcan.com/fr-fr/pdf/rap00_fr.pdf http://www.axcan.com/fr-ca/pdf/rap00_fr.pdf
http://www.axcan.com/pdf/rap00_fr.pdf page 3
duplicates:http://www.axcan.com/fr-fr/pdf/rap00_fr.pdf http://www.axcan.com/fr-ca/pdf/rap00_fr.pdf
trimestre_v1_ang page 3
duplicates:http://www.axcan.com/en-fr/pdf/Q3-E.pdf http://www.axcan.com/en-ca/pdf/Q3-E.pdf
Axcan_Couverts page 27
author: poste 4
duplicates:http://www.axcan.com/en-fr/pdf/rap01.pdf http://www.axcan.com/en-ca/pdf/rap01.pdf
Axcan_Couverts page 26
author: poste 4
duplicates:http://www.axcan.com/en-fr/pdf/rap01.pdf http://www.axcan.com/en-ca/pdf/rap01.pdf
http://www.axcan.com/pdf/rap00.pdf page 24
duplicates:http://www.axcan.com/en-fr/pdf/rap00.pdf http://www.axcan.com/en-ca/pdf/rap00.pdf
http://www.axcan.com/pdf/rap00.pdf page 18
duplicates:http://www.axcan.com/en-fr/pdf/rap00.pdf http://www.axcan.com/en-ca/pdf/rap00.pdf
http://www.axcan.com/pdf/rap00.pdf page 3
duplicates:http://www.axcan.com/en-fr/pdf/rap00.pdf http://www.axcan.com/en-ca/pdf/rap00.pdf
AXP-111/LOWREZ.FR Approbations et lancements de produits ° Axcan a annonce en avril le debut de la commercialisation des suppositoires rectaux de mesalamine (5- ASA) CANASA 500 mg aux Etats- Unis.MESALAMINE (5- ASA) CANASA 500 MG N Axcan a presente des resultats d'etudes qui indiquent que les suppositoires CANASA (5- ASA) sont un moyen efficace de...
author: Mario
Axcan_Couverts CANASA (suppositoires) Traitement de la recto- colite ulcereuse active (forme distale de la colite ulcereuse).MESALAMINE Suppositoire CANASA 500 mg (Etude chez l'enfant) THERAPIE PHOTODYNAMIQUE PHOTOFRIN (cancers) (Canada, E.- U., Europe, Japon) PHOTOFRIN ...
author: poste 4
http://www.axcan.com/pdf/rap00_fr.pdf Canada Nouveau marche ° PHOTOFRIN ° URSO Etats- Unis Nouvelles indications ° PHOTOFRIN ° URSO Nouveau marche ° PHOTOFRIN ° HELICIDE E rope Axcan connait une forte croissance sur trois fronts Augmentation du taux de penetration des marches actuels ° MODULON ° SALOFALK ° PHOTOFRIN Nouveau marche ° HELICIDE Augmentation du taux de...
http://www.axcan.com/pdf/rap02.pdf 76% Net sales $25.7 million CANASA INCREASE Net sales $39.5 million ULTRASE/ VIOKASE 15% Net sales $30.2 million URSO 250 INCREASE 4% INCREASE [ page 8 AXCAN PHARMA ] Several other key development programs were in the spotlight in 2002, as we worked to enhance our long- term profitability with products from our own development portfolio.Mesalamine is one of the key...
trimestre_v1_ang 3 AXCAN PHARMA Third quarter June 30 th , 2001 I terim report President and Chief Executive Officer's Report Dear Shareholders, In the third quarter of 2001, we consolidated our leadership position in the field of specialty pharma gastroenterology in North America and built our presence in Europe.
Axcan_Couverts Approval by the FDA of CANASA 500 mg mesalamine (5- ASA) rectal suppositories for the treatment of active ulcerative proctitis, followed by the U.CANASA, along with the in- licensing of new ursodiol compounds and then the filing of new drug submissions/ applications for two products, PHOTOFRIN in Canada...
author: poste 4
http://www.axcan.com/pdf/rap00.pdf Canada New Indications ° PHOTOFRIN ° URSO United States New Indications ° PHOTOFRIN ° URSO New Markets ° PHOTOFRIN ° HELICIDE E rope Increased Market Penetration ° MODULON ° SALOFALK ° PHOTOFRIN New Products ° HELICIDE Increased Market Penetration ° PHOTOFRIN ° ULTRASE New Products ° CANASA MESALAMINE (5-...
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
21-252_CANASA Suppositories Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Canasa (Mesalamine) Suppositories Company:--Axcan Scandipharm Inc
author: Paul Stauffer
CDER Report to the Nation: 2001 Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2001 Table of Contents 1 Drug Review Index Mission Highlights New Drug Review Standard new drugs Priority new drugs New molecular entities Standard NMEs Priority NMEs Orphan drug approvals Notable 2001 new drug approvals New or Expanded Use Review...
author: OLIVERN
NDA Approvals for Calendar Year 2001 NDA APPROVALS FOR CALENDAR YEAR 2001 Updated through December 31, 2001 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21-252 Canasa Mesalamine Axcan Scandipharm 5 P 05-Jan-01 21-208 Remeron SolTab Mirtazapine Organon 3 S 12-Jan-01 21-227 Cancidas Caspofungin Acetate Merck Research Labs 1 P 26-Jan-01 21-261 Monistat 3...
author: Brenda Harmon
Prescription and OTC Drug Product List 1/2001 Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 1: January 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL - ADD - ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE BISOPROLOL...
